Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Data from SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

(2023)10.1158/2159-8290.c.6679570Source: DataRank Database

Data from SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy is a research paper (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: goldTopics (17)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Manish R. Sharma ORCID,Melissa L. Johnson ORCID,Timothy A. Yap ORCID,Shirish M. Gadgeel ORCID,Dale Nepert ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W4379207144

goldLicense: cc-by

https://doi.org/10.1158/2159-8290.c.6679570

Fields of Study

Protein Tyrosine PhosphatasesATP Synthase and ATPases ResearchColorectal Cancer Treatments and Studies

Keywords

KRASTargeted therapyCancer researchMedicineCancerCombination therapyROS1OncogeneColorectal cancerAcquired resistanceInternal medicineOncologyCell cycleAdenocarcinoma

Sustainable Development Goals

SDG 0: Good health and well-being